Effective management of chronic pain requires an understanding of the underlying pathophysiologic mechanisms that contribute to the sensation of pain. Identifying the different types of pain a patient is experiencing is essential to choosing the appropriate management approach for an individual patient. Practical implementation of diagnostic and assessment tools for differentiation between nociceptive, neuropathic and nociceptive pain can be challenging for clinicians due to time constraints and lack of training. Additionally, distinguishing acute and chronic pain pathways, as well as differentiating acute, subacute (a new term introduced in the 2022 updates to the CDC Guideline for Prescribing Opioids for Chronic Pain), and chronic pain are vital pieces to the puzzle of optimal pain management.
This first installment of a REMS BriefCase series will provide learners with an in-depth review of the underpinnings of pain, implementing a workflow for pain evaluation and risk assessment tools, and how to incorporate multimodal treatment plans in practice to improve the overall health-related quality of life (HRQL) in patients with chronic pain.
At the end of this CME/CE activity, participants should be able to apply knowledge of acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please click here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
Physicians, surgeons, dentists, PAs, nurse practitioners, nurses, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Weimer reports the following financial relationships: Consultant: CVS Health and Path CCM, Inc.
Dr. Patel reports the following financial relationships: Advisory Board: Abbott; Averitas Pharma, Inc.; BIOTRONIK, Inc.; Boston Scientific Corporation; Mainstay Medical; and Relievant Medsystems, Inc. Research Support: Abbott; Speakers Bureau: Abbott; Mainstay Medical; and Relievant Medsystems, Inc.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-22-117-H01-P.
Call us at 877.CME.PROS (877.263.7767).